Oxford BioMedica wins big contract for Novartis cell therapy

LONDON (Reuters) - Novartis has signed a major contract with Oxford BioMedica that could earn the British company more than $100 million over three years for supplying the Swiss drugmaker with material for its novel cell therapy CTL019.

The deal, announced by Oxford BioMedica on Thursday, could help put the veteran biotech firm on a path to sustainable profitability.

The contract is for the supply of lentiviral vectors used to generate CTL019, a new kind of treatment for hard-to-treat leukemia that is expected to reach the market this year.

A U.S. advisory panel will discuss the case for approving CTL019 at a meeting on July 12 and Novartis has already designated the treatment as a potential blockbuster.

Oxford BioMedica will received $10 million from Novartis upfront, as well as payments for various performance incentives and bioprocessing and development services.

It will also get a royalty on future sales of CTL-019. Jefferies analysts said this could earn Oxford BioMedica between 65 million and 75 million pounds ($84-97 million) a year, assuming CTL019 peak sales of at least $1 billion.

The agreement also covers the supply of vectors for other undisclosed Chimeric Antigen Receptor T cell (CART) products.

(Reporting by Ben Hirschler; Editing by Keith Weir)

Related News

Volkswagen caps executive pay, tightens bonus eligibility

Feb 24, 2017

US-VOLKSWAGEN-RESULTS-MANAGEMENTPAY:Volkswagen caps executive pay, tightens bonus eligibility

China-led AIIB approves seven new members ahead of new Silk Road summit

May 13, 2017

US-CHINA-SILKROAD-AIIB:China-led AIIB approves seven new members ahead of new Silk Road summit

Brazil's Supreme Court probes former president, senators

Feb 10, 2017

US-BRAZIL-CORRUPTION-COURT:Brazil's Supreme Court probes former president, senators

Must Read

Volkswagen caps executive pay, tightens bonus eligibility

Feb 24, 2017

US-VOLKSWAGEN-RESULTS-MANAGEMENTPAY:Volkswagen caps executive pay, tightens bonus eligibility

China-led AIIB approves seven new members ahead of new Silk Road summit

May 13, 2017

US-CHINA-SILKROAD-AIIB:China-led AIIB approves seven new members ahead of new Silk Road summit

Brazil's Supreme Court probes former president, senators

Feb 10, 2017

US-BRAZIL-CORRUPTION-COURT:Brazil's Supreme Court probes former president, senators

Search
You May Need To Know

Obserworld delivers the most accurate and up-to-date world news for the global audience with a thorough research and in-depth interviews. Discover the world through Obserworld.

Contact us: sales@obserworld.com